-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Md9+il7sSeWLNY0FgZawHZIJ05mUBZaG2sF7lGrtlgqErN6krEKi+BlrFUbcz1Wg PxSC31sgqCCq9d3WP5CPXg== 0000935836-08-000221.txt : 20080501 0000935836-08-000221.hdr.sgml : 20080501 20080501121305 ACCESSION NUMBER: 0000935836-08-000221 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080331 FILED AS OF DATE: 20080501 DATE AS OF CHANGE: 20080501 EFFECTIVENESS DATE: 20080501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KILKENNY CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001133468 IRS NUMBER: 943219916 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-06279 FILM NUMBER: 08793353 BUSINESS ADDRESS: STREET 1: 737 NORTH MICHIGAN AVE STREET 2: SUITE 2350 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 3129131250 MAIL ADDRESS: STREET 1: 737 NORTH MICHIGAN AVE STREET 2: SUITE 2350 CITY: CHICAGO STATE: IL ZIP: 60611 13F-HR 1 kilkenny13f.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2008 Check here if Amendment:___; Amendment Number:___ This Amendment (Check only one. ___ is a restatement. ___ adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Kilkenny Capital Management L.L.C. Address: 737 North Michigan Avenue Suite 737 Chicago IL 60611 Form 13F File Number:28-06279 The institutional investment manager filing this report and the person by whom it is signed hereby represent that all information contained herein is true correct and complete and that it is understood that all required items statements schedules lists and tables are considered integral parts of this Form. Person Signing this Report on Behalf of Reporting Manager: Name: Michael P. Walsh Title: Executive Manager Phone: 312-913-1250 Signature Place and Date of Signing: Michael P. Walsh Chicago IL April 30, 2008 Report Type (Check only one.: X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report. ___13F NOTICE. (Check here if no holdings reported are in this report and all holdings are reported by other reporting manager(s. ___13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s. Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 1 Form 13F Information Table Entry Total: 64 Form 13F Information Table Value Total: 56,847(X 1000 List of Other Included Managers: Provide a numbered list of the name(s and Form 13F file number(s of all institutional investment managers with respect to which this report is filed other than the manager filing this report. 1Form 13F File Number: 28-10471 Name: Advantage Advisers LLC > NAME OF ISSUER TITLE VALUE SH PUT/ INV. OTHER VOTING AUTH OF CUSIP X1000 SHARES / CALL DISC MGR CLASS PR . N SOLE SHR NONE ALEXION COMMON 015351109 940 15860 SOLE 15860 PHARMACEUTICALS INC SH ALEXION COMMON 015351109 248 4175 1 4175 4175 PHARMACEUTICALS INC SH OTHER ALTUS COMMON 02216N105 1753 385262 SOLE 385262 PHARMACEUTICALS INC SH ALTUS COMMON 02216N105 446 97965 1 97965 97965 PHARMACEUTICALS INC SH OTHER CARDIOME COMMON 14159U202 699 82392 SOLE 82392 PHARMACEUTICAL CORP SH CARDIOME COMMON 14159U202 182 21686 1 21686 21686 PHARMACEUTICAL CORP SH OTHER CELGENE COMMON 151020104 26 418 1 418 418 SH OTHER CEPHALON INC COMMON 145708109 3260 50612 SOLE 50612 SH CEPHALON INC COMMON 145708109 925 14368 1 14368 14368 SH OTHER CEPHALON INC COMMON 156708109 341 5300 1 5300 5300 SH OTHER CRITICAL COMMON 22674T105 417 604909 SOLE 604909 THERAPEUTICS SH CRITICAL COMMON 22674T105 104 150875 1 150875 150875 THERAPEUTICS SH OTHER CUBIST COMMON 229678107 4302 233556 SOLE 233556 PHARMACEUTICALS INC SH CUBIST COMMON 229678107 1079 58569 1 58569 58569 PHARMACEUTICALS INC SH OTHER CUBIST COMMON 229678107 184 10000 1 10000 10000 PHARMACEUTICALS INC SH OTHER CUTERA INC COMMON 232109108 2287 169766 SOLE 169766 SH CUTERA INC COMMON 232109108 602 44684 1 44684 44684 SH OTHER CYPRESS BIOSCIENCES COMMON 232674507 1299 181449 SOLE 181449 SH CYPRESS BIOSCIENCES COMMON 232674507 342 47759 1 47759 47759 SH OTHER CYPRESS BIOSCIENCES COMMON 232674507 222 31000 1 31000 31000 SH OTHER DYAX CORP COMMON 26746E103 3524 748173 SOLE 748173 SH DYAX CORP COMMON 26746E103 888 188435 1 188435 188435 SH OTHER DYAX CORP COMMON 26746E103 271 57500 1 57500 57500 SH OTHER FOREST LABS COMMON 345838106 2647 66161 SOLE 66161 SH FOREST LABS COMMON 345838106 696 17400 1 17400 17400 SH OTHER GENENTECH INC COMMON 368710406 611 7519 SOLE 7519 SH GENENTECH INC COMMON 368710406 186 2294 1 2294 2294 SH OTHER GENZYME CORPORATION COMMON 372917104 2774 37219 SOLE 37219 SH GENZYME CORPORATION COMMON 372917104 711 9545 1 9545 9545 SH OTHER GILEAD SCIENCES INC COMMON 375558103 1036 20107 SOLE 20107 SH GILEAD SCIENCES INC COMMON 375558103 280 5436 1 5436 5436 SH OTHER INSPIRE COMMON 457733103 1753 455198 SOLE 455198 PHARMACEUTICALS INC SH INSPIRE COMMON 457733103 451 117073 1 117073 117073 PHARMACEUTICALS INC SH OTHER ISTA COMMON 45031X204 385 199664 SOLE 199664 PHARMACEUTICALS SH ISTA COMMON 45031X204 122 63353 1 63353 63353 PHARMACEUTICALS SH OTHER LIFECELL COMMON 531927101 2261 53793 SOLE 53793 SH LIFECELL COMMON 531927101 596 14188 1 14188 14188 SH OTHER LIFECELL COMMON 531927101 387 9200 1 9200 9200 SH OTHER MEDAREX COMMON 583916101 69 7858 SOLE 7858 SH MEDAREX COMMON 583916101 13 1500 1 1500 1500 SH OTHER NEUROMETRIX COMMON 641244104 482 265023 SOLE 265023 SH NEUROMETRIX COMMON 641244104 116 63486 1 63486 63486 SH OTHER NEUROMETRIX COMMON 641255104 37 20250 1 20250 20250 SH OTHER ONYX COMMON 683399109 895 30844 SOLE 30844 PHARMACEUTICALS INC SH ONYX COMMON 683399109 236 8119 1 8119 8119 PHARMACEUTICALS INC SH OTHER PENWEST COMMON 709754105 659 253445 SOLE 253445 PHARMACEUTICALS CO SH PENWEST COMMON 709754105 243 93641 1 93641 93641 PHARMACEUTICALS CO SH OTHER PENWEST COMMON 709754105 109 42100 1 42100 42100 PHARMACEUTICALS CO SH OTHER PHARMACOPEIA DRUG COMMON 7171EP101 933 253682 SOLE 253682 DISCOVERY SH PHARMACOPEIA DRUG COMMON 7171EP101 229 62841 1 62841 62841 DISCOVERY SH OTHER PROGENICS COMMON 743187106 1128 172672 SOLE 172672 SH PROGENICS COMMON 743187106 297 45449 1 45449 45449 SH OTHER PROGENICS COMMON 743187106 65 10000 1 10000 10000 SH OTHER TORREYPINES COMMON 05461R101 65 47176 SOLE 47176 THERAPEUTICS SH TORREYPINES COMMON 05461R101 12 8457 1 8457 8457 THERAPEUTICS SH OTHER UNITED THERAPEUTICS COMMON 91307C101 3260 37598 SOLE 37598 CORP 2 SH UNITED THERAPEUTICS COMMON 91307C101 720 8300 1 8300 8300 CORP 2 SH OTHER VALEANT COMMON 91911X104 2768 215767 SOLE 215767 PHARMACEUTICALS SH INTL VALEANT COMMON 91911X104 621 48437 1 48437 48437 PHARMACEUTICALS SH OTHER INTL VION COMMON 927624106 28 17738 1 17738 17738 PHARMACEUTICALS INC SH OTHER VIROPHARMA INC COMMON 928241108 553 61867 SOLE 61867 SH VIROPHARMA INC COMMON 928241108 150 16727 1 16727 16727 SH OTHER ZYMOGENETICS COMMON 98985T109 3105 316863 SOLE 316863 SH ZYMOGENETICS COMMON 98985T109 817 83402 1 83402 83402 SH OTHER
4293\002\EROBERTS\1506341.1
-----END PRIVACY-ENHANCED MESSAGE-----